跳至主要内容
临床试验/CTRI/2020/06/025855
CTRI/2020/06/025855已完成2 期

Efficacy of Ayurveda Intervention (AYUSH 64) as add-on therapy in COVID 19 patients - An open label randomized controlled trial

IPGT and RA0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Asymptomatic or minimal symptomatic COVID 19 patients Patients having 0 to 4 score as per the WHO ordinal scale for clinical improvement
  • Age 18 to 70years
  • Patients who can take oral medicine
  • Patients who are ready to give written consent

排除标准

  • Age below 18 and above 70years
  • Patients having severe symptoms of COVID19
  • Patients on mechanical ventilator or organ support
  • Patients do not able to take oral medication
  • Pregnant and lactating women
  • Oncological diseases and other systemic uncontrol conditions such as HTN diabetes etc
  • Liver or kidney malfunctions.
  • Severe pneumonia Acute respiratory distress syndrome Sepsis and Septic Shock

研究者

发起方
IPGT and RA

相似试验